SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : UTHR-a Promising Biotech in the works here?
UTHR 445.43-1.8%Oct 31 9:30 AM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: JEB who wrote (56)8/10/2001 3:06:24 PM
From: t2  Read Replies (1) of 66
 
The interesting part is still that it has only really recovered from that negative leak..stock was at about $12.60 prior to that. Only gained about $1.20 if one factors out the negative leak that took it below $9.

First major drug for a company with $9 per share in cash and no debt.

Joe Kernan (cnbc) did not know cause of this stock's declines in the past few months--sometimes these could be related to spinoffs. He did not realize that this stock was just so beaten up.

Lots of potential on this one; planning on buying on any weakness;
actually even today's levels seem like a good opportunity,imho.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext